A 5-day-old preterm neonate (34 weeks gestation) born to an Rh-negative mother (unsensitized) presents with jaundice. Serum bilirubin is 14 mg/dL. Direct bilirubin is 0.8 mg/dL. Hemoglobin is 12 g/dL, reticulocyte count is 8%, and direct antiglobulin test (DAT/Coombs) is negative. What is the most appropriate next step in management?

Explanation

## Clinical Context This is a **5-day-old preterm neonate (34 weeks)** with unconjugated hyperbilirubinemia. Key findings: - **Negative DAT** → rules out hemolytic disease (ABO, Rh, other blood group incompatibilities) - **Normal reticulocyte count (8%)** → no significant hemolysis - **Normal hemoglobin** → no anemia - **Low direct bilirubin (0.8 mg/dL)** → predominantly unconjugated (physiological/breastfeeding jaundice) This is **NOT hemolytic disease of the newborn (HDN)** despite Rh-negative mother status (unsensitized = no prior sensitization, DAT negative = no active hemolysis). ## Key Point: **Preterm infants have lower phototherapy thresholds** than term infants because of immature blood–brain barrier and increased risk of bilirubin encephalopathy. Always use the **preterm-specific nomogram**. ## Management Algorithm ```mermaid flowchart TD A[Preterm neonate, Day 5, TSB 14 mg/dL, DAT negative]:::outcome --> B{Hemolysis present?}:::decision B -->|Yes: elevated reticulocyte, anemia, positive DAT| C[Investigate cause: ABO, Rh, G6PD, infection]:::action B -->|No: negative DAT, normal Hb, normal retic| D[Physiological/breastfeeding jaundice]:::outcome D --> E{Preterm or term?}:::decision E -->|Preterm| F[Use preterm phototherapy nomogram]:::action E -->|Term| G[Use term phototherapy nomogram]:::action F --> H[Plot TSB vs. age and gestational age]:::action G --> H H --> I{Above phototherapy threshold?}:::decision I -->|Yes| J[Start phototherapy]:::action I -->|No| K[Recheck TSB in 24 hours, optimize feeding]:::action ``` ## High-Yield: Phototherapy Thresholds (Preterm vs. Term) | Gestational Age | Day 5 TSB Threshold (mg/dL) | |---|---| | 35–37 weeks | ~13–14 | | 38–42 weeks (term) | ~17.5–18 | **At 34 weeks, day 5, TSB 14 mg/dL is AT or NEAR the phototherapy threshold.** The correct next step is to **apply the preterm nomogram** and decide on phototherapy based on that chart. ## Clinical Pearl: **Why preterm infants have lower thresholds:** 1. Immature blood–brain barrier → bilirubin crosses more easily 2. Lower serum albumin and reduced bilirubin binding capacity 3. Increased risk of **acute bilirubin encephalopathy** and **chronic kernicterus** 4. Sepsis, acidosis, and hypoglycemia lower the safe threshold further ## Tip: **Always check:** 1. **Maternal blood type and antibody screen** → rules out Rh/ABO/other incompatibility 2. **DAT (Coombs)** → rules out hemolytic disease 3. **Reticulocyte count and hemoglobin** → assesses for hemolysis 4. **Gestational age** → determines which phototherapy nomogram to use In this case, negative DAT + normal reticulocyte + unsensitized Rh-negative mother = **no hemolytic disease**. The jaundice is physiological/nutritional. Management is phototherapy per **preterm nomogram**. [cite:AAP Neonatal Jaundice Guidelines 2009; Cloherty & Stark Ch 18]